3.5. Changes in Plasma Levels of KS, HA, HAPLN1, ADAMTS4, ADAMTS5, TOS and TGF-β in Patients with JIA during ETA Treatment. Here, HAPLN1 is linked to juvenile idiopathic arthritis.